Relmada Therapeutics, Inc. (RLMD)
2.615
-0.50
(-15.92%)
USD |
NASDAQ |
Nov 20, 16:00
Relmada Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2014 | 0.00% |
| September 30, 2013 | |
| August 31, 2013 | |
| May 31, 2013 | 50.00% |
| February 28, 2013 | 21.74% |
| Date | Value |
|---|---|
| November 30, 2012 | 14.29% |
| August 31, 2012 | 33.33% |
| May 31, 2012 | 25.00% |
| February 29, 2012 | 25.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Talphera, Inc. | -- |
| Journey Medical Corp. | 63.87% |
| ANI Pharmaceuticals, Inc. | 54.92% |
| Corcept Therapeutics, Inc. | 98.65% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.94% |
| Return on Assets | -42.74% |
| Return on Invested Capital | -45.94% |
| Return on Net Operating Assets | -4.36K% |